Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS1 | P09382 | 2/20 | 0.42 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.42 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.42 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | PYGB | P11216 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | OGA | O60502 | 5/20 | 0.36 |
| ▸ | HEXA | P06865 | 1/20 | 0.36 |
| ▸ | HEXB | P07686 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21037780 | 1.00 | LGALS1 (0.42) | LGALS1LGALS3LGALS9LGALS8ALDH1A1 | |
| SCHEMBL22768244 | 0.93 | ALDH1A1 (0.40) | LGALS1LGALS3LGALS9LGALS8ALDH1A1 | |
| SCHEMBL12563251 | 0.84 | LGALS1 (0.43) | LGALS1LGALS3LGALS9LGALS8ALDH1A1 | |
| SCHEMBL13324374 | 0.84 | LGALS1 (0.43) | LGALS1LGALS3LGALS9LGALS8ALDH1A1 | |
| SCHEMBL13896454 | 0.84 | LGALS1 (0.43) | LGALS1LGALS3LGALS9LGALS8ALDH1A1 | |
| SCHEMBL29124797 | 0.84 | LGALS1 (0.43) | LGALS1LGALS3LGALS9LGALS8ALDH1A1 | |
| SCHEMBL14257099 | 0.84 | LGALS1 (0.43) | LGALS1LGALS3LGALS9LGALS8ALDH1A1 | |
| SCHEMBL16604340 | 0.84 | LGALS1 (0.43) | LGALS1LGALS3LGALS9LGALS8ALDH1A1 | |
| SCHEMBL17225751 | 0.84 | LGALS1 (0.43) | LGALS1LGALS3LGALS9LGALS8ALDH1A1 | |
| SCHEMBL25518939 | 0.84 | LGALS1 (0.43) | LGALS1LGALS3LGALS9LGALS8ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11518777-B2 | Inhibitors of the shikimate pathway | EBERHARD KARLS UNIVERSITÄT TÜBINGEN (DE) | 2022-12-06 | — | — | US | disclosed |
| US-20200385416-A1 | NOVEL INHIBITORS OF THE SHIKIMATE PATHWAY | EBERHARD KARLS UNIVERSITÄT TÜBINGEN (DE) | 2020-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200385416-A1 | NOVEL INHIBITORS OF THE SHIKIMATE PATHWAY | HK1, HKDC1, TKT | LGALS1 3303/4885LGALS3 3784/4885LGALS9 2925/4885 |
| US-11518777-B2 | Inhibitors of the shikimate pathway | TKT, HK1, HKDC1 | LGALS1 3347/4885LGALS3 3779/4885LGALS9 2706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.